ArticleMultiple sclerosis journal - experimental, translational and clinical

Subcutaneous interferon β-1a three times weekly and the natural evolution of gadolinium-enhancing lesions into chronic black holes in relapsing and progressive multiple sclerosis: Analysis of PRISMS and SPECTRIMS trials.

A Traboulsee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.